EMA — authorised 20 February 2014
- Marketing authorisation holder: GALDERMA INTERNATIONAL
- Status: approved
🇪🇺 Alphagan in European Union
EMA authorised Alphagan on 20 February 2014
Marketing authorisation
Alphagan in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Cardiovascular approved in European Union
Frequently asked questions
Is Alphagan approved in European Union?
Yes. EMA authorised it on 20 February 2014.
Who is the marketing authorisation holder for Alphagan in European Union?
GALDERMA INTERNATIONAL holds the EU marketing authorisation.